Literature DB >> 2157282

The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity.

J H Weiss1, D M Hartley, J Koh, D W Choi.   

Abstract

High concentrations of potent N-methyl-D-aspartate (NMDA) agonists can trigger degeneration of cultured mouse cortical neurons after an exposure of only a few minutes; in contrast, selective non-NMDA agonists or low levels of NMDA agonists require exposures of several hours to induce comparable damage. The dihydropyridine calcium channel antagonist nifedipine was used to test whether this slow neurotoxicity is mediated by a calcium influx through voltage-gated channels. Nifedipine had little effect on the widespread neuronal degeneration induced by brief exposure to high concentrations of NMDA but substantially attenuated the neurotoxicity produced by 24-hour exposure to submaximal concentrations of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate, kainate, or quinolinate. Calcium ion influx through dihydropyridine-sensitive, voltage-dependent calcium channels may be an important step in the neuronal injury induced by the prolonged activation of NMDA or non-NMDA glutamate receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157282     DOI: 10.1126/science.2157282

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures.

Authors:  E M Blalock; N M Porter; P W Landfield
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  L-arginyl-3,4-spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission.

Authors:  Barclay Morrison; Ashley K Pringle; Terence McManus; John Ellard; Mark Bradley; Francesco Signorelli; Fausto Iannotti; Lars E Sundstrom
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 4.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 5.  Interrelationship between retinal ischaemic damage and turnover and metabolism of putative amino acid neurotransmitters, glutamate and GABA.

Authors:  L N Robin; M Kalloniatis
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

6.  cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons.

Authors:  E T Kavalali; K S Hwang; M R Plummer
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

7.  Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid.

Authors:  J F Reinhard
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

8.  Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons.

Authors:  Y Cheng; A Y Sun
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

Review 9.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

10.  A host GPCR signaling network required for the cytolysis of infected cells facilitates release of apicomplexan parasites.

Authors:  Melanie G Millholland; Satish Mishra; Christopher D Dupont; Melissa S Love; Bhumit Patel; Dustin Shilling; Marcelo G Kazanietz; J Kevin Foskett; Christopher A Hunter; Photini Sinnis; Doron C Greenbaum
Journal:  Cell Host Microbe       Date:  2013-01-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.